NO923240L - Nye heparinderivater - Google Patents

Nye heparinderivater

Info

Publication number
NO923240L
NO923240L NO92923240A NO923240A NO923240L NO 923240 L NO923240 L NO 923240L NO 92923240 A NO92923240 A NO 92923240A NO 923240 A NO923240 A NO 923240A NO 923240 L NO923240 L NO 923240L
Authority
NO
Norway
Prior art keywords
heparin derivatives
treating
approximately
temperature
heparin
Prior art date
Application number
NO92923240A
Other languages
English (en)
Other versions
NO923240D0 (no
Inventor
Francesco Della Valle
Aurelio Romeo
Guenter Kirschner
Original Assignee
Fidia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Spa filed Critical Fidia Spa
Publication of NO923240D0 publication Critical patent/NO923240D0/no
Publication of NO923240L publication Critical patent/NO923240L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

Lav-molekylvekt heparinderivater og salter derav er fremstilt ved behandling av et kvaternært ammoniumsalt av et heparin, opplest i et heterosyklisk organisk opplesningsmiddel eller i et aprotisk opplesningsmiddel, ned et alkylerende middel, som har fra 6-30 karbonatomer, ved en temperatur på tilnærmet 20°-60°C, i en forlenget tidsperiode, og behandling av det resulterende reaksjonsprodukt, ved en temperatur på tilnærmet 5e-120°C, med en uorganisk eller organisk base, såsom et alkalisk hydroksid, i vandig opplesning, og isolering av de oppnådde heparinderi- vater i sin frie form eller som et alkalisk salt derav. Heparinderivatene oppnådd i henhold til fremgangsmåten i den foreliggende oppfinnelse utgjør en blanding av for det meste depolymeriserte produkter med molekylvekter innenfor et trangt område. Disse produkter er nyttige som antitrombotiske midler.
NO92923240A 1990-12-20 1992-08-18 Nye heparinderivater NO923240L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT04175290A IT1243300B (it) 1990-12-20 1990-12-20 Derivati dell'eparina
PCT/EP1991/002479 WO1992011294A1 (en) 1990-12-20 1991-12-20 Heparin derivatives

Publications (2)

Publication Number Publication Date
NO923240D0 NO923240D0 (no) 1992-08-18
NO923240L true NO923240L (no) 1992-10-19

Family

ID=11253436

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92923240A NO923240L (no) 1990-12-20 1992-08-18 Nye heparinderivater

Country Status (13)

Country Link
EP (1) EP0516792A1 (no)
JP (1) JPH05504785A (no)
KR (1) KR920703644A (no)
CN (1) CN1062537A (no)
AU (1) AU658594B2 (no)
BR (1) BR9106234A (no)
CA (1) CA2075970A1 (no)
FI (1) FI923762A0 (no)
HU (1) HUT62917A (no)
IT (1) IT1243300B (no)
NO (1) NO923240L (no)
PT (1) PT99898A (no)
WO (1) WO1992011294A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2663639B1 (fr) * 1990-06-26 1994-03-18 Rhone Poulenc Sante Melanges de polysaccharides de bas poids moleculaires procede de preparation et utilisation.
FR2704861B1 (fr) * 1993-05-07 1995-07-28 Sanofi Elf Fractions d'héparine purifiées, procédé d'obtention et compositions pharmaceutiques les contenant.
ES2077533B1 (es) * 1994-02-28 1996-07-01 Bioiberica Procedimiento de obtencion de fracciones de oligosacaridos por despolimerizacion quimica de heparina.
US5639469A (en) * 1994-06-15 1997-06-17 Minnesota Mining And Manufacturing Company Transmucosal delivery system
US5744457A (en) * 1995-03-31 1998-04-28 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5763427A (en) * 1995-03-31 1998-06-09 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US6001820A (en) * 1995-03-31 1999-12-14 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
CN1114410C (zh) * 1996-03-15 2003-07-16 宝酒造株式会社 糖醛酸类的热处理产物、以及含有这种产物的食品、饮料和药物
US5767269A (en) * 1996-10-01 1998-06-16 Hamilton Civic Hospitals Research Development Inc. Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics
FR2763848B1 (fr) * 1997-05-28 2000-01-28 Rhone Poulenc Rorer Sa Utilisation des heparines de bas poids moleculaire pour la prevention et le traitement du trauma du systeme nerveux central
DE10217557A1 (de) * 2002-04-19 2003-11-06 Degussa Bioactives Gmbh Funktionsnahrungsmittel enthaltend eine Phospholipid-haltige stabile Matrix
WO2003088949A2 (de) * 2002-04-19 2003-10-30 Bioghurt Biogarde Gmbh & Co. Kg. Matrix mit einer bioaktiven phospholipid-haltigen komponente
CN100335506C (zh) * 2004-05-20 2007-09-05 汕头市金丰医疗器械科技有限公司 一种肝素化合物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2482603A1 (fr) * 1980-05-14 1981-11-20 Pharmindustrie Nouveaux esters d'heparine utilisables pour la preparation de medicaments, et procedes pour leur preparation
ES2071608T3 (es) * 1986-08-20 1995-07-01 Univ Miami Esteres de alcanoilo de heparina de bajo peso molecular.
SE8702254D0 (sv) * 1987-05-29 1987-05-29 Kabivitrum Ab Novel heparin derivatives

Also Published As

Publication number Publication date
IT9041752A0 (it) 1990-12-20
IT9041752A1 (it) 1992-06-21
JPH05504785A (ja) 1993-07-22
PT99898A (pt) 1992-12-31
BR9106234A (pt) 1993-03-30
FI923762A (fi) 1992-08-20
FI923762A0 (fi) 1992-08-20
KR920703644A (ko) 1992-12-18
WO1992011294A1 (en) 1992-07-09
CA2075970A1 (en) 1992-06-21
EP0516792A1 (en) 1992-12-09
AU658594B2 (en) 1995-04-27
CN1062537A (zh) 1992-07-08
IT1243300B (it) 1994-05-26
NO923240D0 (no) 1992-08-18
AU9096491A (en) 1992-07-22
HUT62917A (en) 1993-06-28

Similar Documents

Publication Publication Date Title
NO923240L (no) Nye heparinderivater
Kleinpeter The structure of hydantoins in solution and in the solid state
ES8403480A1 (es) Un procedimiento para la preparacion de nuevos tiojenos o furanos.
ES409081A1 (es) Procedimiento para la preparacion de hidroxiaril-tetrame- til-piperidinas.
DE3762615D1 (de) Verfahren zur herstellung von (2,2)-paracyclophan und dessen derivaten.
EP0293539A3 (en) Process for the depolymerization of heparin for obtaining heparin with a low molecular weight and having an antithrombotic activity
PT99134A (pt) Processo para a preparacao de derivados da piperazina
Vargha et al. 151. Synthesis of new sugar derivatives of potential antitumour activity. Part I. Ethyleneimino-and 2-chloroethylamino-derivatives
US3632806A (en) Novel n - pyridylmethylidene - homo-cysteine thiolactone compound and the preparation thereof
Nishiguchi et al. Acid-catalyzed isomerization of 1-acyl-and 1-thioacylaziridines. I. Mechanism of nucleophilic substitution
Koopman et al. Investigations on herbicides I. 2‐(Substituted amino)‐4, 6‐dichloro‐1, 3, 5‐triazines
IT1190317B (it) Procedimento chimico per la preparazione di derivati dell'ossamide e composti cosi' ottenuti
ES8307267A1 (es) "procedimiento para la preparacion de un polimero".
US2810726A (en) Alpha-halo-alpha'-imino-substituted pyrrolines and piperideines and their acid saltsand method for their preparation
US3635995A (en) 2-(2-imidazolin-2-yl)methylthiopyridine-n-oxide and derivatives thereof
US3234229A (en) Nitrogen compounds of polychloro-2-(trichloromethyl)pyridines
KR840001968A (ko) 4-페닐퀴나졸린 유도체의 제조방법
CN110698392A (zh) 一种双酰胺类化合物及其制备方法与应用
US3459742A (en) Sulfanilamide derivatives and processes
US2793215A (en) 2, 5-bis-(substituted-mercapto)-3, 4-dicyanopyrroles and their preparation
US2723190A (en) Organic sulfur compounds and herbicides containing same
US2507830A (en) Methane sulfonic acid salt of di
US3530141A (en) Process for preparing 1,1'-dialkyl-4,4'-bipyridylium compounds
Brown et al. Rate of Solvolysis of 1-(p-Anisyl) camphene Hydrochloride. Evidence for the Absence of Significant Carbon Participation in the Solvolysis of a Tertiary Norbornyl Derivative
US2457484A (en) Substituted pyridine compound